What actions can you take now to fortify your legal operations as a growing biotech company?
Discover the key strategies that will transform your biotech's legal operations and drive growth by watching our recent webinar,
It was an insightful session, as our panel of industry leaders, including Factor’s Karl Dorwart, Cerevel Therapeutics’ Scott Akamine and Umoja Biopharma’s Chris Moore, discussed how a robust legal operations foundation can power your biotech growth.
As a recap, some of the key takeaways included:
- Scott Akamine, Chief Legal Officer, Cerevel Therapeutics, highlighted that biotechs often face unpredictable resource fluctuations which impact how legal must operate and plan: "You're going to go through cycles of rapid growth and contraction that have nothing to do with your department, but have everything to do with the success of [the company's therapies or products in development], and macroeconomic factors… and the legal department is always going to be riding in the backseat there and supporting the rest of the business."
- Karl Dorwart, VP, Life Sciences, Factor, emphasized the importance of legal professionals in biotech thinking beyond just legal and considering broader business goals: "You don't want to show up and be 'the lawyer in the room.' You want to show them that you're thinking about how we’re going to get this technology compliantly through the clinical trial phase."
- Chris Moore, Chief Legal Officer, Umoja Biopharma, discussed the importance of creating processes and templates for recurring tasks to improve efficiency: "If you do anything more than once, you should think about how you're doing it... if a ramp or wheel is technology, then so is a template and a playbook."
We invite you to watch the recording on-demand:
